In situ non-canonical activation and sensitization of cGAS-STING pathway with manganese telluride nanosheets.

Gao, Hongbo; Sun, Li; Wang, Han; Ji, Xiuru; Shen, Qianwen; Chen, Di; Jiao, Yuxin; Ni, Dalong et al. · Biomaterials · 2025

basic_science · Level V

Where this comes from

Abstract

Immune checkpoint blockade (ICB) has achieved encouraging outcome in various malignant tumors. However, the low immunogenicity and insufficient infiltration of T cells within tumors severely limit the curative effects. Herein, we reported synthesis and experimental evaluation of H<sub>2</sub>O<sub>2</sub>-responsive MnTe<sub>2</sub> nanosheets (NSs) for improving anti-tumor immune responses. Within the tumor microenvironment characterized by high level of H<sub>2</sub>O<sub>2</sub>, the MnTe<sub>2</sub> NSs were degraded to release Mn<sup>2+</sup> and TeO<sub>4</sub><sup>2-</sup> which subsequently induced cellular endoplasmic reticulum (ER) stress and non-canonically activated the cGAS-STING pathway. Moreover, the cellular Mn<sup>2+</sup> ions enhanced the sensitivity of cGAS-STING pathway and the maturation of dendritic cells (DCs) concurrently. Ultimately, the MnTe<sub>2</sub> NSs exhibited favorable in vivo anti-tumor immune effects, especially in combination with PD-L1 checkpoint inhibitors. These findings provided compelling evidence for exploration and utilization of nanomedicine to leverage innate immune system for better tumor immunotherapy.

Medical subject headings